Publications:

  • Garegg, P J & T Norberg: Synthesis of O-ß-D-glucopyranosyl-(1-3)-O-a-L-fucopyranosyl-L-threonine. Carbohyd Res. 1976, 52, 235-240.

  • Erbing, B, B Lindberg & T Norberg: Synthesis of O-ß-D-galactopyranosyl-(1-4)-O-ß-D-xyolopyranosyl-L-serine. Acta Chem Scand. 1978, B 32, 308-310.

  • Garegg, P J, H Hultberg & T Norberg: Synthesis of two 3-O-(3,6-dideoxy-a-D-xylo-hexapyranosyl)-a-D-mannopyranosides suitable for covalent attachment to a protein carrier. Carbohydr Res. 1981, 96, 59-64.

  • Garegg, P J & T Norberg: Syntheses of the biological repeating units of salmonella serogroups A, B, and D1 O-antigenic polysaccharides. J Chem Soc Perkin Trans. 1982, I, 2973-2982.

  • Garegg, P J & T Norberg: Synthesis of p-nitrophenyl 3-O-(2-acetamido-2-deoxy-ß-D-glucopyranosyl)-a-L-rhamnopyranoside corresponding to a fragment of the Streptococcus group A cell wall polysaccharide. Acta Chem Scand. 1982, B 36, 65-66.

  • Kallin, E, H Lönn & T Norberg: New derivatization and separation procedures for reducing oligosaccharides. Glycoconjugate J. 1986, 3, 311-319.

  • Kallin, E, H Lönn & T Norberg: Derivatization procedures forreducing oligosaccharides, Part 2: Chemical transformation of 1-deoxy-1-(4-trifluoroacetamidophenyl)aminoalditols. Glycoconjugate J. 1988, 5, 145-150.

  • Nilsson, M & T Norberg: Synthesis of carbohydrate derivatives corresponding to a tumor-associated glycolipid: A trimeric Lewis x nonasaccharide and a trimeric N-acetyllactosamine hexasaccharide. J. Carbohydr. Chem., 1989,8, 613-627.

  • Lüning, B, T. Norberg & J. Tejbrant: Synthesis of mono- and disaccharide amino acid derivatives for use in solid phase peptide synthesis. Glycoconjugate J. 1989, 6, 5-19.

  • Nilsson,M & T Norberg: Synthesis of a monofucosyl heptasaccharide corresponding to a tumor-associated glycolipid defined by monoclonal antibody ACFH-18.J. Carbohydr. Chem., 1990, 9, 1-14.

  • Lüning, B, T. Norberg & J. Tejbrant: Solid-phase synthesis of mono- and disaccharide containing glycopeptides. J. C. S. Chem. Comm., 1989, 1267-1268.

  • Kallin,E, H Lönn, T Norberg & M. Elofsson: Derivatization procedures for reducing oligosaccharides, Part 3: Preparation of oligosaccharide glycosylamines, and their conversion into oligosaccharide-acrylamide copolymers. J. Carbohydr. Chem., 1989, 8, 597-611.

  • Kallin, E, H Lönn, &T Norberg: Synthesis of p-trifluoroacetamidophenylethyl O-(2-acetamido-2-deoxy-ß-D-galactopyranosyl-(1-4)-O-ß-D-galactopyranosyl-(1-4)-O-ß-D-glucopyranoside, containing the trisaccharide portion of the asialo-GM2 glycolipid. J. Carbohydr. Chem., 1990, 9, 721-733.

  • Kallin, E, H Lönn, T Norberg, T. Sund & M. Elofsson: Derivatization procedures for reducing oligosaccharides, Part 4: Use of glycosylamines in a reversible derivatization of oligosaccharides with the 9-fluorenylmethyloxycarbonyl group, and HPLC separation of the derivatives. J. Carbohydr. Chem., 1991, 10, 377-86.

  • Chernyak, A. Ya., A. Weintraub, T Norberg & E. Kallin: Preparation of oligosaccharide-polyacrylamide conjugates and their use as antigens in enzyme immunoassays (EIA). Glycoconjugate J., 1990, 7, 111-120.

  • Nilsson, S, H. Lönn & T Norberg: Synthesis of two tumor-associated oligosaccharides: di- and trifucosylated para-lacto-N-hexaose. J. Carbohydr. Chem., 1991, 10, 1023-1048.

  • Lüning B., T. Norberg, C. Rivera-Baeza, and J. Tejbrant: Solid-phase synthesis of the fibronectin glycopeptide V(Galb3GalNAca)THPGY, and its b analog. Glycoconjugate J., 1991, 8, 450-55.

  • Helland, A., M. Nilsson and T. Norberg: Synthesis of a trifucosyl Lewis y heptasaccharide corresponding to a tumor-associated glycolipid. J. Carbohydr. Chem., 1992, 11, 77-88.

  • Nilsson, S, Bengtsson, M. and Norberg, T.: Solid-phase synthesis of a fragment of the capsular polysaccharide of Haemopilus influenzae using H-phosphonate intermediates. J. Carbohydr. Chem., 1992, 11, 265-85.

  • Blomberg, L, and T. Norberg: Immobilization of reducing oligosaccharides to matrixes by a glycosylamide linkage. J. Carbohydr. Chem., 1993, 12, 265-76.

  • Eklind, K., R. Gustafsson, A.-K. Tidén, T. Norberg and P.-M. Åberg: Large-scale synthesis of a Lewis B tetrasaccharide derivative, its acrylamide copolymer, and related di- and trisaccharides for use in adhesion inhibition studies with helicobacter pylori. J Carbohydr. Chem., 15 (1996) 1141-1168.

  • O. Blixt and T. Norberg: Solid-phase enzymatic synthesis of a Lewis a trisaccharide using an acceptor reversibly bound to Sepharose. J Carbohydr. Chem., 16, (1997), 143-154.

  • G. Thiele and T. Norberg: Synthesis of haptens for generating antibodies that catalyze selective acylation of a carbohydrate derivative. J Carbohydr. Chem., 17, (1998), 143-152.

  • Nilsson,M., Norberg, T.: Solid-phase synthesis of an analog of Haemophilus influenzae type b capsular polysaccharide. J Carbohydr. Chem., 17, (1998), 305-316.

  • Blixt, O., Norberg, T.: Solid-phase enzymatic synthesis of a sialyl Lewis x tetrasaccharide on a Sepharose matrix, (1998) J. Org. Chem. 63, 1998, 2705-2710.

  • M. Nilsson and T. Norberg: Synthesis of a spacer-containing nonasaccharide fragment of Streptococcus 19F capsular polysaccharide. J Chem Soc Perkin 1, (1998), 1699.

  • O. Blixt and T. Norberg : Enzymatic glycosylation of reducing oligosaccharides linked to a solid phase or a lipid via a cleavable squarate linker. Carbohydr. Res., 319 (1999) 80-91.

  • M. Nilsson and T. Norberg: Synthesis of a spacer-containing disaccharide fragment of Bordetella pertussis lipopolysaccharide. Carbohydr. Res., 327 (2000), 261.

  • M. Bårström, M. Bengtsson, O. Blixt and T. Norberg: New lipophilic derivatives of reducing oligosaccharides and their use in enzymatic reactions: Efficient synthesis of sialyl lewis a and sialyl dimeric Lewis x glycoconjugates. Carbohydr. Res., 328 (2000), 525.

  • U. Westerlind, P. Hagback, M. Duk, T. Norberg: Synthesis and inhibitory activity of a di- and a trisaccharide corresponding to an erythrocyte glycolipidresponsible for the NOR polyagglutination. Carbohydr. Res., 337, (2002) 1517-1522.

  • M. Duk, U. Westerlind, T. Norberg, G. Pazynina, N. N. Bovin, and E. Lisowska: Specificity of human anti-NOR antibodies, a distinct species of"natural" anti--galactosyl antibodies. Glycobiology 13 (2003) 279-284.

  • J. Kang, W. Low, T. Norberg, J. Meisenhelder, K. Hansson, J. Stenflo, G.-P. Zhou, J. Imperial, B. M. Olivera, A.C. Rigby, A.G. Craig: Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is a-D-Gal-(1-3)-a-D-GalNAc. Eur.J.Biochem. 271 (2004) 4939 -4949.

  • U. Westerlind, J. Westman, E. Törnquist, C. I. E. Smith, S. Oscarson, M.Lahmann, T. Norberg: Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine. Glycoconjugate J. 21 (2004) 227-41.

  • U. Westerlind, P. Hagback, B. Tidbäck, L. Wiik, O. Blixt, N. Razi, T. Norberg: Synthesis of deoxy and acylamino derivatives of lactose and use of these for probing the active site of Neisseria meningitidis N-acetylglucosaminyltransferase. Carbohydr. Res., 340 (2005) 221-233.

  • Eklund, E. A., Merbouh, N., Ichikawa, M., Nishikawa, A., Clima, J. M., Dorman, J. A., Norberg, T., Freeze, H. H.: Hydrophobic Man-1-P derivatives correct abnormal glycosylation in type I congenital disorder of glycosylation fibroblasts. Glycobiology, 15 (2005) 1084-1093.

  • U. Westerlind, T. Norberg: Chemical synthesis of analogs of the glycopeptide contulakin-G, an analgetically active conopeptide from Conus geographus. Carbohydr. Res., 341 (2006) 9-18.

  • A.S. Norgren, T. Norberg, P.I. Arvidsson: Glycosylated foldamers: synthesis of carbohydrate-modified beta3hSer and incorporation into beta-peptides. J. Pept. Sci., 13 (2007) 717-27.

  • O. Blixt, J. Hoffmann, S. Svenson, T. Norberg: Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies. Glycoconjugate J., 25 (2008) 27-36.

  • Q. Zhang, T. Norberg, J. Bergquist, L. Baltzer: Synthesis of C-11 linked active ester derivatives of vitamin D3 and their conjugations to 42-residue helix-loop-helix peptides. Tetrahedron 66 (2010) 4577-4586.

  • Tegler, L. T., Nonglaton, G., Buttner, F., Caldwell, K., Christopeit, T., Danielson, U. H., Fromell, K, Gossas, T., Larsson, A., Longati, P., Norberg, T., Ramapanicker, R., Rydberg J., and Baltzer, L.: Powerful Protein Binders from Designed Polypeptides and Small Organic Molecules - A general Concept for Protein Recognition. Angew. Chem. Int. Ed. 50 (2011) 1823-1827.

  • Slosarczyk, A. T., Ramapanicker, R., Norberg, T., and Baltzer, L: Mixed pentafluorophenyl and o-fluorophenyl esters of aliphatic dicarboxylic acids: efficient tools for peptide and protein conjugation. RSC Advances, 2 (2012) 908-914, DOI: 10.1039/C1RA00530H

  • Sun, X., Yang, J., Norberg, T., and Baltzer, L: A synthetic polypeptide conjugate from a 42-residue polypeptide and salicylhydroxamic acid binds human myeloperoxidase with high affinity. J. Peptide Sci. 18 (2012) 731-739, DOI: 10.1002/psc.2459

  • Srivastava, L., Tundup, S., Choi, B-S., Norberg, T., Harn, D: Immunomodulatory Glycan Lacto-N-Fucopentaose III Requires Clathrin-Mediated Endocytosis To Induce Alternative Activation of Antigen-Presenting Cells. Infect. Immun. 82 (2014) 1891-1903 (doi: 10.1128/IAI.01293-13).

  • Tundup, S., Srivastava, L., Norberg, T., Watford, W., Harn, D: A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway. PLoS ONE 10 (2015) e0137495. (doi:10.1371/journal.pone.0137495.

  • Al-Smadi, D., Reddy Enugala, T., Kessler, V., Ranu Mhashal, A., Kamerlin, S.C. L., Kihlberg,J., Norberg, T., and Widersten, M.: Chemical and Biochemical Approaches for the Synthesis of Substituted Dihydroxybutanones and Di-, and Tri-Hydroxypentanones. J. Org. Chem. 84 (2019), 11, 6982-6991 (doi: 10.1021/acs.joc.9b00742).

  • Norberg, T.; Kallin, E.; Blixt, O.: Reversible derivatization of sugars with carbobenzyloxy groups and use of the derivatives in solution-phase enzymatic oligosaccharide synthesis. Carbohydr. Res., 502 (2021) 108272. (https://doi.org/10.1016/j.carres.2021.108272).

  • Brown, K.A., Carpenter, J.M., Preston, C. J., Ludwig, H.D., Clay, K. B., Harn, D.A., Norberg, T., Wagner, J. J., Filipov, N.M.: Lacto-N-fucopentaose-III ameliorates acute and persisting hippocampal synaptic plasticity and transmission deficits in a Gulf War Illness mouse model . Life Sciences 279 (2021) 119707 (doi: 10.1016/j.lfs.2021.119707).

  • Norberg, T., Kallin, E., Johansson, G: Derivatization of sugars with N,O-dimethylhydroxylamine. Efficient RP-HPLC separation of sugar mixtures. Carbohyd. Res. 520 (2022) 108635 (doi: 10.1016/j.carres.2022.108635).

  • Norberg, T., Kallin, E.: N-methyl-O-benzylhydroxylamine derivatives of sialylated oligosaccharides, their synthesis and separation with reversed-phase HPLC. Carbohyd. Res. 533 (2023) 108939 (doi: https://doi.org/10.1016/j.carres.2023.108939

  • Cornelius, E. C., Bartl, M., Persson, L. J., Xiong, R., Cederfelt, D., Rad, F. M., Norberg, T., Engel, S., Marklund, E., Dobritzsch, D., Widersten, M.: Engineered Aldolases Catalyzing Stereoselective Aldol Reactions Between Aryl-Substituted Ketones and Aldehydes. Catal. Sci. Technol. (2023) in press. doi: https://doi.org/10.1039/D3CY00181D

  • Carpenter, J.M., Brown,,, K.A., Veltmaat, L., Ludwig, H.D., Clay, K. B., Norberg, T., Harn, D.A., Wagner, J. J., Filipov, N.M.: Evaluation of delayed LNFPIII treatment initiation protocol on improving long-term behavioral and neuroinflammatory pathology in a mouse model of Gulf War Illness. Brain, Behavior, & Immunity - Health 26, (2022) 100553. doi: https://doi.org/10.1016/j.bbih.2022.100553


Mail toWebmaster